Published in Br J Clin Pharmacol on January 01, 1979
The effect of captopril (SQ14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. J Physiol (1982) 0.96
Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension. Proc Natl Acad Sci U S A (2004) 0.95
Aminopeptidase A inhibitors as centrally acting antihypertensive agents. Heart Fail Rev (2008) 0.83
Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension. Int J Hypertens (2012) 0.82
Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states. Eur J Clin Invest (1971) 2.59
A slowly developing pressor response to small concentrations of angiotensin. Its bearing on the pathogenesis of chronic renal hypertension. Lancet (1963) 1.65
Measurement of concentrations of angiotensin I in human blood by radioimmunoassay. Clin Sci (1973) 1.58
Role of the pressor action of angiotensin II in experimental hypertension. Circ Res (1971) 1.49
Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides. Proc Soc Exp Biol Med (1972) 1.37
Hypertension of renal origin: evidence for two different mechanisms. Science (1971) 1.16
Contrasting exchangeable sodium in rats with different types of Goldblatt hypertension. Am J Physiol (1969) 1.10
Inhibition of angiotensin conversion and prevention of renal hypertension. Am J Physiol (1975) 1.10
Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science (1973) 1.06
Arterial hypertension elicited by subpressor amounts of angiotensin. Science (1965) 1.04
Stimulation of renal sodium reabsorption by angiotensin II. Am J Physiol (1977) 0.97
Salt and water balance and renin activity in renal hypertension of rats. Am J Physiol (1975) 0.96
Intrarenal control of electrolyte excretion by angiotensin II. Am J Physiol (1977) 0.95
Radioimmunoassay of angiotensin II in the rat. J Endocrinol (1976) 0.94
Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotension-induced hypertension in dogs. Circ Res (1976) 0.93
Pathogenesis of arterial hypertension after the constriction of the renal artery leaving the opposite kidney intact both in the anaesthetized and in the conscious dog. Clin Sci (1972) 0.91
Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors. Lancet (1978) 0.89
Mechanism of renal hypertension. Lancet (1976) 0.89
Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat. Circ Res (1975) 0.84
The pressor role of angiotensin in salt deprivation and renal hypertension in rats. Clin Sci Mol Med Suppl (1975) 0.80
Effect of angiotensin-converting enzyme inhibitor (SQ 20881) on the plasma concentration of angiotensin I, angiotensin II, and arginine vasopressin in the dog during hemorrhagic shock. Circ Res (1977) 0.79
The course of arterial pressure and the effect of Sar1-Thr8-angiotensin II in a new model of two-kidney hypertension in conscious dogs. Clin Sci Mol Med (1977) 0.78
Renal control of interstitial space compliance: a physiological mechanism which may play a part in the etiology of hypertension. Clin Nephrol (1975) 0.77
The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects. Aust N Z J Med (1976) 0.77
Fluid balance, renal function, and blood pressure. Clin Nephrol (1975) 0.77
TEMPERATURE EFFECT OF POPLITEAL VEIN LIGATION IN THROMBO-ANGIITIS OBLITERANS AND ARTERIOSCLEROSIS. Ann Surg (1928) 28.36
THE EFFECT OF ROENTGEN RAYS ON THE RATE OF GROWTH OF SPONTANEOUS TUMORS IN MICE. J Exp Med (1915) 13.91
Biochemical detection of left-ventricular systolic dysfunction. Lancet (1998) 7.51
THE LYMPHOCYTE IN NATURAL AND INDUCED RESISTANCE TO TRANSPLANTED CANCER : II. STUDIES IN LYMPHOID ACTIVITY. J Exp Med (1915) 5.45
THE PRODUCTION OF LYMPHOMATOSIS IN MICE OF KNOWN GENETIC CONSTITUTION. Science (1938) 4.28
Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet (1992) 4.18
Diverticulitis of the Colon. Ann Surg (1946) 3.86
Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ (1989) 3.74
The Treatment of Ileus: As Indicated by Clinical Experience and Experimental Studies. Ann Surg (1932) 3.37
SYMPATHETIC INHIBITION OF THE LARGE INTESTINE IN HIRSCHSPRUNG'S DISEASE. J Clin Invest (1930) 3.29
Reduced thirst after water deprivation in healthy elderly men. N Engl J Med (1984) 3.13
Captopril in heart failure. A double blind controlled trial. Br Heart J (1984) 2.85
INTERINNOMINO-ABDOMINAL (HINDQUARTER) AMPUTATION. Ann Surg (1942) 2.81
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J (1985) 2.74
Evaluation of vulneray activity by an open wound procedure in rats. Arch Int Pharmacodyn Ther (1972) 2.70
Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J (1970) 2.33
Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. Br J Clin Pharmacol (1976) 2.25
Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) (1985) 2.14
An Evaluation of Pulmonary Embolism following Intravascular Venous Thrombosis. Ann Surg (1947) 2.11
Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J Pharmacol Exp Ther (1987) 2.09
Skin tumors following a single application of methylcholanthrene in C57 brown mice. Am J Pathol (1939) 2.04
Minimum effective dosage in the drug treatment of hypertension. N Z Med J (1990) 1.93
Medical Investigation of Retinal Vascular Occlusion. Br Med J (1964) 1.93
Lead and delta-aminolaevulinic acid dehydratase levels in mentally retarded children and in lead-poisoned suckling rats. Lancet (1970) 1.93
Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. Lancet (1970) 1.90
The estimation of renin in human plasma. Biochem J (1964) 1.85
Essential hypertension: a disorder of growth with origins in childhood? J Hypertens (1992) 1.85
STUDIES ON THE ACTIVITY OF THE LUMBAR SYMPATHETIC NERVOUS SYSTEM. Ann Surg (1930) 1.83
Plasma Renin Concentration in Human Hypertension-III: Renin in Relation to Complications of Hypertension. Br Med J (1966) 1.83
Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. Br J Clin Pharmacol (1982) 1.81
NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J (2006) 1.81
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart (2001) 1.77
Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension (1990) 1.77
Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke. Cerebrovasc Dis (2006) 1.77
Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) (1982) 1.76
Circulating dopamine: its effect on the plasma concentrations of catecholamines, renin, angiotensin, aldosterone and vasopressin in the conscious dog. Clin Sci (Lond) (1981) 1.76
Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens (1986) 1.71
Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet (1980) 1.68
Renin and acute renal failure: studies in man. Br Med J (1970) 1.66
Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients. Clin Pharmacol Ther (1980) 1.64
Chondrosarcoma. Ann Surg (1947) 1.60
Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens (1992) 1.60
Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension (1980) 1.60
A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chim Acta (1980) 1.58
The estimation of renin in plasma by an enzyme kinetic technique. Biochem J (1964) 1.56
OBSTRUCTIONS ABOUT THE MESENTERY IN INFANTS. Ann Surg (1936) 1.54
Countercurrent exchange between the vasa recta and the loop of Henle. Lancet (1966) 1.52
Salt and hypertension. Lancet (1984) 1.52
Psychiatric disturbance leading to potassium depletion, sodium depletion, raised plasma-renin concentration, and secondary hyperaldosteronism. Lancet (1968) 1.49
Purification of pig renin. Biochem J (1966) 1.48
Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction. J Am Coll Cardiol (1999) 1.47
Plasma endothelin in chronic heart failure. Circulation (1992) 1.47
Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension (1991) 1.46
Renin and angiotensin. A survey of some aspects. Postgrad Med J (1966) 1.45
Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature (1981) 1.42
Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. Eur J Pharmacol (1987) 1.42
Pharmacological and cardiovascular properties of a hydantoin derivative, BW 245 C, with high affinity and selectivity for PGD2 receptors. Prostaglandins (1983) 1.40
Treatment of hypertension. N Z Med J (1989) 1.39
Excess smoking in malignant-phase hypertension. Br Med J (1979) 1.38
Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care. Eur J Heart Fail (2007) 1.38
Letter: Intravenous labetalol in severe hypertension. Lancet (1975) 1.37
Potent new inhibitors of human renin. Nature (1982) 1.37
A radioimmunoassay for plasma arginine-vasopressin in man and dog: application to physiological and pathological states. J Endocrinol (1975) 1.37
Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet (1971) 1.37
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet (1979) 1.37
Concurrent estimation of total body and exchangeable body sodium in hypertension. Clin Sci Mol Med (1978) 1.34
Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension. Lancet (1979) 1.34
Plasma renin concentration and the control of blood pressure in patients on maintenance haemodialysis. Nephron (1969) 1.33
Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration. Br Med J (1975) 1.32
Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease? J Hum Hypertens (1988) 1.31
New sialic acids. Identification of N-glycoloyl-O-acetylneuraminic acids and N-acetyl-O-glycoloylneuraminic acids by improved methods for detection of N-acyl and O-acyl groups and by gas-liquid chromatography. Eur J Biochem (1974) 1.31
Microangiopathic haemolytic anaemia and the pathogenesis of malignant hypertension. Lancet (1969) 1.31
Renin and angiotensin as a mechanism of diuretic-induced antidiuresis in diabetes insipidus. Lancet (1969) 1.30
Severe hypokalaemia with paralysis induced by small doses of liquorice. Postgrad Med J (1980) 1.29
The Similarity in Effect of Experimental High Intestinal Obstruction and High Complete Intestinal Fistula. Ann Surg (1931) 1.29
Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. J Pharmacol Exp Ther (1990) 1.27
Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol. Br J Clin Pharmacol (1976) 1.22
Neurological dysfunction in two patients receiving captopril and cimetidine. Lancet (1980) 1.20
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure. Br J Clin Pharmacol (1982) 1.19
Plasma renin concentration in human hypertension . II. Renin in relation to aetiology. Br Med J (1965) 1.19
Measurement of plasma angiotensin II. Clin Sci (Lond) (1985) 1.19
Sodium and potassium in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.18
Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Lancet (1975) 1.18